Winton Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,300
| Closed | -$283K | – | 982 |
|
|
2022
Q1 | $283K | Buy |
+7,300
| New | +$283K | 0.01% | 832 |
|
|
2021
Q4 | – | Sell |
-3,582
| Closed | -$212K | – | 1130 |
|
|
2021
Q3 | $212K | Buy |
+3,582
| New | +$212K | 0.01% | 1224 |
|
|
2021
Q2 | – | Sell |
-6,111
| Closed | -$504K | – | 1447 |
|
|
2021
Q1 | $504K | Buy |
6,111
+2,381
| +64% | +$196K | 0.03% | 886 |
|
|
2020
Q4 | $339K | Buy |
+3,730
| New | +$339K | 0.02% | 982 |
|